PPH Legal Blog

Lannett Inc, a pharmaceutical company, has received approval from the FDA to go ahead and market Phentermine Hydrochloride. They received approval via their Abbreviated New Drug Application.
Phentermine Hydrochloride is intended to be a treatment option in the battle against obesity. Lannett hopes to begin selling their product as soon as possible.
Phentermine is by no means […]

[Read more →]

The Chili Bowl II, held December 1st in Savannah Georgia, is an event designed to raise money for a local Savannah family that has massive medical bills. This year’s beneficiary was David Sisk, a 39 year-old father of 2 who has been diagnosed with Primary Pulmonary Hypertension.
Mr. Sisk was recently diagnosed with PPH and faces […]

[Read more →]

An 18 year-old girl that was struck with Primary Pulmonary Hypertension is thankful to experience this Christmas with her family and friends. Without a dual-lung and heart transplant in February, she most likely would not have made it to Christmas.
The 18 year-old, while still happy to be here, feels a tinge of sadness for her […]

[Read more →]

The Phase III trial study for Actelion-1 is about to begin. This phase of the trials will test the safety and effectiveness of the new drug.
Actelion and Tracleer are seen as revolutionizing the treatment options for people with primary pulmonary hypertension and primary arterial hypertension.
The study will have 180 centers with 500 patients. These 500 […]

[Read more →]

The family of nurse Milagros Larosa, 65, has filed a wrongful death lawsuit against the maker of Avandia, GlaxoSmithKline.
In the course of a year, Ms. Larosa was hospitalized 3 times for heart problems. Prior to taking Avandia, she had not had any heart problems or heart conditions. Ms. Larosa died of a stroke in December […]

[Read more →]